Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part II-specific NE tumour types.
Part II of the guidelines contains a description of epidemiology, histopathology, clinical presentation, diagnostic procedure, treatment, and survival for each type of neuroendocrine tumour. We are not only including gastroenteropancreatic tumours but also bronchopulmonary and thymic neuroendocrine tumours. These guidelines essentially cover basic knowledge in the diagnosis and management of the different forms of neuroendocrine tumour. We have, however, tried to give more updated information about the epidemiology and histopathology, which is essential for the clinical management of these tumours.
Oberg
Kjell
K
Department of Endocrine Oncology, University Hospital, Uppsala, Sweden. kjell.oberg@medsci.uu.se
Astrup
Lone
L
Eriksson
Barbro
B
Falkmer
Sture E
SE
Falkmer
Ursula G
UG
Gustafsen
Jens
J
Haglund
Caj
C
Knigge
Ulrich
U
Vatn
Morten H
MH
Välimäki
Matti
M
D005770:Gastrointestinal Neoplasms / Q000453:epidemiology / Q000473:pathology; D006801:Humans; D008175:Lung Neoplasms / Q000453:epidemiology / Q000473:pathology; D018358:Neuroendocrine Tumors / Q000453:epidemiology / Q000473:pathology; D010190:Pancreatic Neoplasms / Q000453:epidemiology / Q000473:pathology; D013953:Thymus Neoplasms / Q000453:epidemiology / Q000473:pathology